Science
Sudo Biosciences lead programs target TYK2, which is believed to be linked to serious immunological and neurological conditions. The company’s research focuses on serious conditions with medical need, with the goal of delivering transformative therapeutics for patients.
Team
Company management includes experienced scientists and leaders in small molecule drug discovery and development. Our highly collaborative culture focuses on ground-breaking research, with a focus on rapidly advancing therapeutics for serious conditions with medical needs.
Careers
Intellectual curiosity defines the Sudo Biosciences work environment. We are dedicated to the recruitment, training, and career development of each team member.
© 2025 Sudo Biosciences, Inc. All rights reserved. Privacy Notice